RS174547 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial co..."
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid) | C | OR: 1.69 | 3E-971 | PubMed |
| lysoPhosphatidylcholine acyl C20:4 levels | T | OR: 42.68 | 4E-398 | PubMed |
| Phosphatidylcholine diacyl C36:4 levels | T | OR: 37.83 | 3E-313 | PubMed |
| Lysophosphatidylethanolamine_22:4_[M-H]1- levels | C | OR: 0.35 | 9E-284 | PubMed |
| Lipid metabolism phenotypes | — | OR: 0.57 | 8E-262 | PubMed |
| Lysophosphatidylcholine_20:4_[M+H]1+ levels | C | OR: 0.41 | 7E-261 | PubMed |
| 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) levels | C | OR: 0.46 | 2E-189 | PubMed |
| Phosphatidylcholine acyl-alkyl C36:5 levels | T | OR: 29.03 | 2E-185 | PubMed |
| Adrenic Acid levels (331.2643_0.397) | — | OR: 0.41 | 3E-180 | PubMed |
| Metabolite levels | T | OR: 0.15 | 7E-179 | PubMed |
| lysoPhosphatidylcholine acyl C20:4 levels | T | OR: 0.17 | 2E-175 | PubMed |
| Phosphatidylcholine diacyl C38:4 levels | T | OR: 0.14 | 9E-172 | PubMed |
| Adrenic Acid levels (331.2643_0.397) x waist circumference interaction (2df) | — | — | 4E-163 | PubMed |
| Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid) | T | β: 0.07 | 4E-154 | PubMed |
| Phosphatidylethanolamine_38:4_[M-H]1- levels | C | OR: 0.22 | 4E-149 | PubMed |
| Cholesteryl ester_20:5_[M+NH4]1+ levels | C | OR: 0.31 | 4E-148 | PubMed |
| Low density lipoprotein cholesterol levels | C | β: 0.043 | 2E-143 | PubMed |
| Phosphatidylcholine diacyl C36:4 levels | T | OR: 0.12 | 9E-141 | PubMed |
| Phosphatidylcholine_37:4_[M+H]1+/Phosphatidylethanolamine_40:4_[M+H]1+/Phosphatidate_42:5_[M+NH4]1+ levels | C | OR: 0.38 | 5E-130 | PubMed |
| Fatty acid(20:4)_[M-H]1- levels | C | OR: 0.19 | 9E-122 | PubMed |